MiR-222 accelerates the progression of inflammatory breast cancer by targeting tumor suppressor gene p27kip1 (CDKN1B)

被引：0
|
作者：
Ogony, Joshua Were
Hayes, Erin
Knapp, Jennifer
Lewis-Wambi, Joan
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1900
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1900
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation
    le Sage, Carlos
    Nagel, Remco
    Egan, David A.
    Schrier, Mariette
    Mesman, Elly
    Mangiola, Annunziato
    Anile, Corrado
    Maira, Giulio
    Mercatelli, Neri
    Ciafre, Silvia Anna
    Farace, Maria Giulia
    Agami, Reuven
    EMBO JOURNAL, 2007, 26 (15): : 3699 - 3708
  • [2] MiR-222 regulates the progression of oral squamous cell carcinoma by targeting CDKN1B
    Chen, Qun
    Wang, Wenjuan
    Wang, Yali
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (07): : 5215 - 5227
  • [3] The unpredictable consequences of CDKN1B/p27Kip1 mutations in cancer
    Borriello, Adriana
    Bencivenga, Debora
    Della Ragione, Fulvio
    CELL CYCLE, 2015, 14 (18) : 2865 - 2866
  • [4] p27Kip1 and Tumors: Characterization of CDKN1B Variants Identified in MEN4 and Breast Cancer
    Bencivenga, Debora
    Stampone, Emanuela
    Azhar, Jahanzaib
    Parente, Daniela
    Ali, Waqar
    Del Vecchio, Vitale
    Della Ragione, Fulvio
    Borriello, Adriana
    CELLS, 2025, 14 (03)
  • [5] miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway
    Wang, Dan-dan
    Yang, Su-jin
    Chen, Xiu
    Shen, Hong-Yu
    Luo, Long-ji
    Zhang, Xiao-hui
    Zhong, Shan-liang
    Zhao, Jian-hua
    Tang, Jin-hai
    TUMOR BIOLOGY, 2016, 37 (11) : 15315 - 15324
  • [6] miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27kip1 expression
    Wang, Dan-dan
    Li, Jian
    Sha, Huan-huan
    Chen, Xiu
    Yang, Su-jin
    Shen, Hong-Yu
    Zhong, Shan-liang
    Zhao, Jian-hua
    Tang, Jin-hai
    GENE, 2016, 590 (01) : 44 - 50
  • [7] Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia
    Georgitsi, Marianthi
    Raitila, Anniina
    Karhu, Auli
    van der Luijt, Rob B.
    Aalfs, Cora M.
    Sane, Timo
    Vierimaa, Outi
    Makinen, Markus J.
    Tuppurainen, Karoliina
    Paschke, Ralph
    Gimm, Oliver
    Koch, Christian A.
    Gundogdu, Sadi
    Lucassen, Anneke
    Tischkowitz, Marc
    Izatt, Louise
    Aylwin, Simon
    Bano, Gul
    Hodgson, Shirley
    De Menis, Ernesto
    Launonen, Virpi
    Vahteristo, Pia
    Aaltonen, Lauri A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08): : 3321 - 3325
  • [8] Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1
    Lloyd, Katie A.
    Moore, Andrew R.
    Parsons, Bryony N.
    O'Hara, Adrian
    Boyce, Malcolm
    Dockray, Graham J.
    Varro, Andrea
    Pritchard, D. Mark
    ONCOTARGET, 2016, 7 (29) : 45462 - 45478
  • [9] MiR-222 promotes the progression of polycystic ovary syndrome by targeting p27 Kip1
    Huang, Xiaolan
    She, Liping
    Luo, Xiangmin
    Huang, Shuzhen
    Wu, Jinxiang
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (05) : 918 - 923
  • [10] miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1
    Sun, Chaoyang
    Li, Na
    Zhou, Bo
    Yang, Zongyuan
    Ding, Dong
    Weng, Danhui
    Meng, Li
    Wang, Shixuan
    Zhou, Jianfeng
    Ma, Ding
    Chen, Gang
    ONCOLOGY LETTERS, 2013, 6 (02) : 507 - 512
12345